*ST Jingfeng: Announcement on Determining Pre-Restructuring Investors and Risk Alerts
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Morgan Stanley (China) Limited's interim report on entrusted management of Hunan Jingfeng Pharmaceutical Co., Ltd.'s 2016 public issuance of corporate bonds (first tranche) for qualified investors.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement on the progress of the shareholders' shareholding plan for the company, which has passed half of the time.
Hunan Jingfeng Pharmaceutical: Legal opinion of the first bondholders' meeting of 2024 for 16 Jingfeng 01 of Hunan Jingfeng Pharmaceutical Co., Ltd. by Zhong Lun Law Firm in Beijing.
Hunan Jingfeng Pharmaceutical: Announcement from Morgan Stanley (China) Limited on the First Bondholders Meeting of 2024 for the Public Issuance of Corporate Bonds (First Tranche) by Hunan Jingfeng Pharmaceutical Co., Ltd. for Qualified Investors in 2016
Hunan Jingfeng Pharmaceutical: Announcement Regarding the Postponement of Recruiting Restructuring Investors.
Hunan Jingfeng Pharmaceutical: Morgan Stanley (China) Limited's interim report on entrusted management of Hunan Jingfeng Pharmaceutical Co., Ltd.'s 2016 public issuance of corporate bonds (first tranche) for qualified investors.
Hunan Jingfeng Pharmaceutical: Announcement Regarding Special Risk Warning.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations and severe abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement on the Public Recruitment of Investors for Restructuring
Hunan Jingfeng Pharmaceutical: Announcement Regarding Company's Pre-Reshuffle Debt Application
Hunan Jingfeng Pharmaceutical: Announcement regarding the temporary administrator appointed by the court during the pre-reorganization period of the company.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
No Data